JAMA Editors' Choice 2025: Clinical Reviews Podcasts
JAMA Clinical Reviews
JAMA Deputy Editor Mary McDermott, MD, and JAMA Deputy Editor Kristin Walter, MD, MS, highlight their selections of top JAMA Clinical Reviews podcasts in 2025.
info_outline
From the JAMA Network: JAMA Research of the Year With Editor in Chief Kirsten Bibbins-Domingo
JAMA Clinical Reviews
In this episode, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and Medical News Director Jennifer Abbasi discuss the journal’s inaugural Research of the Year roundup. Related Content:
info_outline
WHO Guideline on the Use and Indications of GLP-1 Therapies for the Treatment of Obesity in Adults
JAMA Clinical Reviews
Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, relapsing disease. WHO recently published a guideline in JAMA on the use and indications of GLP-1 therapies for the...
info_outline
Head and Neck Cancer
JAMA Clinical Reviews
Head and neck cancer is the seventh most common cancer worldwide and is commonly associated with tobacco and alcohol use, or human papillomavirus (HPV) infection. Author Lara Dunn, MD, of Memorial Sloan Kettering Cancer Center joins JAMA...
info_outline
How Climate Change Affects Allergic Rhinitis and Sinusitis
JAMA Clinical Reviews
Allergic rhinitis affects about 1 in 6 US adults. A recent JAMA Insights summarizes evidence regarding the associations of climate change and air pollution with allergic rhinitis and sinusitis. The discussion includes prevention and...
info_outline
Cannabis and Cannabinoids for Therapeutic Purposes
JAMA Clinical Reviews
Clinicians should weigh benefits against risks when engaging patients in informed discussions about cannabis or cannabinoid use. Kevin Hill, MD, MHS, of Harvard Medical School joins JAMA Senior Editor Karen Lasser, MD, MPH, to discuss the...
info_outline
Diagnosis and Treatment of Peripheral Neuropathy
JAMA Clinical Reviews
Peripheral neuropathy affects approximately 1% of adults worldwide and can be associated with significant disability. Author Michelle Mauermann, MD, of the Mayo Clinic in Minnesota joins JAMA Deputy Editor Mary M. McDermott, MD, to...
info_outline
Diagnosis and Treatment of MASLD
JAMA Clinical Reviews
Metabolic dysfunction-associated steatotic liver disease (MASLD), an increasingly prevalent condition among adults worldwide, is associated with liver-related complications, hepatocellular carcinoma, and certain extrahepatic cancers....
info_outline
Moving Toward a Safer World by 2040
JAMA Clinical Reviews
The JAMA Summit on Firearm Violence convened 60 thought leaders from a wide array of disciplines to chart a roadmap that could lead to substantial reductions in firearm harms by 2040. Frederick P. Rivara, MD, MPH, of the University of...
info_outline
Treatment of Keratinocyte Carcinoma
JAMA Clinical Reviews
Keratinocyte carcinomas, which include basal cell carcinoma and squamous cell carcinoma, are common forms of skin cancer. Approximately 5.4 million keratinocyte carcinomas are diagnosed in the US annually. Author Mackenzie R. Wehner, MD,...
info_outlineA patent foramen ovale (PFO) is present in approximately 25% of all adults. Author David M. Kent, MD, MS, of Tufts Medical Center and JAMA Associate Editor David Simel, MD, MHS, discuss how to evaluate the likelihood that a PFO was causal in a patient with a cryptogenic ischemic stroke, and closure of a PFO to lower the incidence of recurrent strokes for affected patients.
Related Content:
- Patent Foramen Ovale and Stroke
- Patent Foramen Ovale and Dysarthria in a Man in His 60s
- Management of Patients With a Patent Foramen Ovale With History of Stroke or TIA
- Heterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After Stroke
- Transesophageal Echocardiogram Detecting a High-Risk Patent Foramen Ovale
-----------------------------------